k.batista
TL2 Moderator · Graz
Contributes reviews on supplier material. Based in Graz.
Joined 3 September 2025 · last posted 8d
81 posts, newest first. Showing up to 150.
-
Private prescribing in the UK: what is actually involved Replied, post #70 · Regional › UK & Ireland · 20 Jul 2026 · 27 likes Worth separating two things that post #66 runs together. Regional variation in NHS: access varies dramatically by region depending on local commissioning decisions and…
-
Rewriting my first post: a before-and-after, with commentary — what changed since Replied, post #17 · Start Here › How to Ask · 18 Jul 2026 · 0 likes Disagreeing with an answer you got: cite what you disagree with, say what contradicts it, and ask which one holds. Do not open with "I think you are wrong". Lead with…
-
Spreadsheets: an appreciation — what changed since Replied, post #97 · Lounge › Off topic · 11 Jul 2026 · 24 likes Science communication: if you come across an interesting science paper or article about peptides or metabolism, sharing it and discussing the idea is on-topic.
-
Asking a follow-up: new topic or new reply? Replied, post #39 · Start Here › How to Ask · 5 Jul 2026 · 27 likes On post #35 — agreed on the reasoning, with one qualification. Arithmetic questions: write out the steps. "I have a 10 mg vial, I added 2 mL, I want a 0.25 mg dose, and…
-
Follow-up: Comparing two chromatograms from different laboratories, properly Replied, post #53 · Analytics › HPLC & UHPLC · 2 Jul 2026 · 0 likes post #52 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Revisiting: The best-written scientific paper you have read Replied, post #53 · Lounge › Off topic · 26 Jun 2026 · 3 likes Newer drugs and mechanisms: when a new drug launches or a new mechanism is discovered, the Lounge is a place to discuss the news and speculate before hard data exists.
-
Second pass at: Which categories are strict and which are relaxed, honestly Replied, post #79 · Start Here › Welcome · 21 Jun 2026 · 25 likes Trust levels accumulate over time and they give you access to small things like the ability to edit your own posts without a timestamp. They are not a status symbol and…
-
Micronutrient adequacy at low total intake Replied, post #68 · Nutrition & Training › Protein & intake · 12 Jun 2026 · 3 likes post #67 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Second pass at: Temperature logging at home: what is worth the effort Replied, post #8 · Practice › Storage & stability · 5 Jun 2026 · 3 likes Refrigeration slows degradation. Repeated warming and cooling is worse than continuous refrigeration. Light exposure is worth avoiding. The concentration matters…
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #19 · Sourcing › Red flags · 3 Jun 2026 · 2 likes post #18 is right about the mechanism and I think understates the practical bit. Inconsistency across documents: a certificate stating one purity, a website claiming…
-
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #48 · Practice › Storage & stability · 1 Jun 2026 · 9 likes Protecting from light: amber vials or opaque containers reduce light exposure. If you are storing for long periods and light matters, this is worth doing. For…
-
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #17 · Compounds › Secretagogues & GH axis · 30 May 2026 · 24 likes What a well-designed human trial of a secretagogue would look like: randomised, placebo-controlled, adequate sample size, IGF-1 as primary outcome, muscle and strength…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #55 · Practice › Reconstitution · 22 May 2026 · 6 likes The decimal-point error: computing 5 mg / 2 mL as 0.25 mg/mL instead of 2.5 mg/mL is the most common arithmetic error in this subcategory. The habit that catches it:…
-
Reading a trial's population section before its results Replied, post #27 · Evidence › Trials · 17 May 2026 · 0 likes Picking up post #24: that is the part I would want checked first. Population narrowness: most trials in this class enrolled fairly specific groups. Baseline body mass…
-
Restarting after a long gap: what the labelling implies — the long version Replied, post #15 · Practice › Dosing & titration · 14 May 2026 · 6 likes post #14 is right about the mechanism and I think understates the practical bit. Micro-titration: the concept of increments smaller than the labelled steps. It has no…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #127 · Practice › Reconstitution · 26 Apr 2026 · 12 likes post #126 is right about the mechanism and I think understates the practical bit. Swirling versus inverting versus leaving it alone: the vial can be gently warmed…
-
Second pass at: What a 2 ppm match establishes, and what it does not Replied, post #6 · Analytics › Mass spectrometry · 23 Apr 2026 · 0 likes Picking up post #3: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #18 · Practice › Reconstitution · 18 Apr 2026 · 22 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
List price versus negotiated price versus what you pay Replied, post #74 · Access › Pricing · 14 Apr 2026 · 24 likes Biosimilars and future generics: as patents expire, biosimilar and generic versions might become available and prices might fall. That has already happened for some…
-
What "marked as solution" means and who gets to mark it — does this still hold? Replied, post #63 · Start Here › Welcome · 7 Apr 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #74 · Practice › Reconstitution · 24 Mar 2026 · 14 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #31 · Lounge › Introductions · 10 Mar 2026 · 0 likes Worth separating two things that post #27 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #26 · Compounds › Cagrilintide & amylin analogues · 25 Feb 2026 · 9 likes post #25 is right about the mechanism and I think understates the practical bit. For anyone arriving from searches on "amylin agonist": this subcategory discusses…
-
Follow-up: Bug report: the reconstitution calculator and a rounding edge case Replied, post #52 · Data & Tools › Calculators · 20 Feb 2026 · 30 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Coming back to: Why most self-reports here are not experiments, and that is fine Replied, post #47 · Research Methods › N-of-1 designs · 19 Feb 2026 · 16 likes Coming back to post #45, because the follow-up matters more than the original answer. Blinding: blinding yourself (not knowing which condition you are in) removes…
-
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #64 · Start Here › How to Ask · 16 Feb 2026 · 25 likes post #63 is right about the mechanism and I think understates the practical bit. Arithmetic questions: write out the steps. "I have a 10 mg vial, I added 2 mL, I want a…
-
Journal club: orforglipron phase 2 and the non-peptide question Started this topic · Evidence › Journal club · 12 Feb 2026 · 27 likes Journal club: orforglipron phase 2 and the non-peptide question Writing it up because I had to work it out twice and would rather nobody else did. I have seen SUSTAIN 6…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #11 · Analytics › Mass spectrometry · 12 Feb 2026 · 1 like post #10 answers the question as asked. The question underneath it is different. Mass accuracy is expressed in parts per million. It is the difference between observed…
-
Aggregates and why a purity assay may miss them entirely Replied, post #53 · Analytics › Impurities & related substances · 6 Jan 2026 · 0 likes Picking up post #50: that is the part I would want checked first. Truncation products: fragments from incomplete synthesis or from degradation. They elute quite…
-
Impurity thresholds: where the common numbers come from — what changed since Replied, post #2 · Analytics › Impurities & related substances · 30 Dec 2025 · 17 likes Deletion sequences (incomplete coupling during synthesis): lower in mass by one residue. Chromatographically they usually elute earlier or later depending on the…
-
Waist circumference technique and its repeatability Replied, post #32 · Outcomes › Progress reports · 29 Dec 2025 · 28 likes Longitudinal report with the method stated: same scale, same time of day, same conditions. A scale is a tool; use the same one each time. Consistency matters more than…
-
Reconstitution volumes that produce round numbers, tabulated Replied, post #5 · Practice › Reconstitution · 7 Dec 2025 · 4 likes I read post #3 twice before replying, because I had assumed the opposite. The decimal-point error: computing 5 mg / 2 mL as 0.25 mg/mL instead of 2.5 mg/mL is the most…
-
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #104 · Compounds › Other compounds · 26 Nov 2025 · 15 likes post #103 is right about the mechanism and I think understates the practical bit. Distinguishing marketed research compounds from true chemical synthesis: some online…
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #60 · Analytics › Home & field testing · 22 Nov 2025 · 5 likes Sample handling matters: if a sample is contaminated or degraded before testing, the test gives you the result for the degraded sample, not for fresh material. That is…
-
An inter-laboratory comparison on one lot, tabulated Replied, post #4 · Analytics › Method validation · 8 Oct 2025 · 6 likes Robustness: the method gives consistent results when minor parameters vary. Tested by deliberately varying pH, temperature, flow rate, and mobile phase composition…
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #59 · Compounds › Cagrilintide & amylin analogues · 3 Oct 2025 · 24 likes This follows post #56 rather than contradicting it. The dosing interval: cagrilintide's half-life is roughly 7 to 8 days, suitable for weekly dosing. The…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #47 · Data & Tools › Datasets · 8 Sep 2025 · 1 like I read post #45 twice before replying, because I had assumed the opposite. How to contribute: if you have longitudinal data you want to add, the format is simple: date,…
-
Journal club: STEP-HFpEF and symptom endpoints Replied, post #11 · Evidence › Journal club · 3 Sep 2025 · 0 likes TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not finished. When it does, this discussion will return to it.
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Started this topic · Compounds › Semaglutide · 22 Aug 2025 · 22 likes Semaglutide half-life: where the 165 to 184 hour figure comes from — setting out what I have, and where I think it stops being reliable. Comparing FLOW ( N Engl J Med ,…
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #7 · Compounds › Semaglutide · 11 Aug 2025 · 2 likes The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology studies. A signal in rodents does not automatically appear in humans, but it…
-
How to research a compound with no human data without deceiving yourself Replied, post #27 · Compounds › Other compounds · 31 Jul 2025 · 6 likes Picking up post #24: that is the part I would want checked first. Naming conventions for research peptides cause confusion because suppliers do not follow a standard.…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #91 · Compounds › Semaglutide · 28 Jul 2025 · 0 likes Is there a ceiling dose beyond which the effect plateaus? The trials did not study that because they stopped at 2.4 mg. Some people report trying higher doses, but…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #11 · Compounds › Secretagogues & GH axis · 25 Jul 2025 · 10 likes Picking up post #8: that is the part I would want checked first. Secretagogues and glucose tolerance: there is a mechanistic concern that sustained growth hormone…
-
What this community means by "a source", in practical terms Replied, post #30 · Start Here › Welcome · 10 Jul 2025 · 24 likes Worth separating two things that post #26 runs together. Nothing here requires expertise. The experienced members here got that way by posting questions, not by knowing…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #61 · Compounds › Repair & healing peptides · 7 Jul 2025 · 7 likes Worth separating two things that post #57 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #41 · Sourcing › Regulatory · 4 Jul 2025 · 30 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #78 · Practice › Storage & stability · 3 Jul 2025 · 8 likes Vial integrity: once a vial is entered with a needle repeatedly, the rubber closure degrades and the integrity fails. Using the same vial repeatedly over weeks or…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #15 · Practice › Reconstitution · 22 Jun 2025 · 6 likes Swirling versus inverting versus leaving it alone: the vial can be gently warmed (hands around it) and swirled with a rolling motion. Vigorous shaking introduces air…
-
Triple agonism: additive, synergistic, or neither? Replied, post #55 · Compounds › Retatrutide · 10 Jun 2025 · 2 likes This follows post #52 rather than contradicting it. Triple agonism: is the effect additive, synergistic, or neither? A phase 2 comparison of tirzepatide (dual) to…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #129 · Practice › Reconstitution · 8 Jun 2025 · 0 likes A vial that will not fully dissolve: check in order: is the diluent genuinely room temperature (some preservatives crystallise in cold), is the vial being warmed gently…
-
Half-life, steady state, and accumulation worked through Replied, post #71 · Pharmacology › Pharmacokinetics · 5 Jun 2025 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
HbA1c lag and what it can and cannot tell you at eight weeks Replied, post #18 · Clinical › Bloodwork · 21 May 2025 · 29 likes I read post #16 twice before replying, because I had assumed the opposite. A single value outside interval: usually uninformative on a single draw. What makes a result…
-
IGF-1 as a surrogate endpoint and its limitations — the long version Replied, post #4 · Compounds › Secretagogues & GH axis · 20 May 2025 · 22 likes On the opening post — agreed on the reasoning, with one qualification. What a well-designed human trial of a secretagogue would look like: randomised,…
-
Pregnancy as an absolute contraindication Replied, post #86 · Safety › Contraindications · 20 May 2025 · 19 likes post #85 is right about the mechanism and I think understates the practical bit. Diabetic retinopathy complications: a signal for this was noted in SUSTAIN 6. Current…
-
Second pass at: Reading a combination trial: attributing effect to components Replied, post #17 · Compounds › Cagrilintide & amylin analogues · 18 May 2025 · 0 likes post #16 answers the question as asked. The question underneath it is different. Cagrilintide molecular characteristics: it is a synthetic amylin analogue, substituted…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #40 · Data & Tools › Calculators · 29 Apr 2025 · 1 like post #39 answers the question as asked. The question underneath it is different. Mass error checking: enter your observed mass and theoretical mass and check whether…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #52 · Evidence › Journal club · 19 Apr 2025 · 7 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #11 · Compounds › Oral incretins · 28 Mar 2025 · 25 likes Worth separating two things that post #7 runs together. Oral bioavailability is variable between people. Some people absorb well; others absorb poorly. That…
-
A supplier that answers analytical questions with restated claims Replied, post #43 · Sourcing › Red flags · 21 Mar 2025 · 8 likes post #42 answers the question as asked. The question underneath it is different. Exaggerated claims without documentation: every compound has limits. No peptide is…
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #38 · Documentation › Doc review · 27 Feb 2025 · 28 likes On post #34 — agreed on the reasoning, with one qualification. Evidence synthesis requests: if you think a page should summarise the state of evidence on a question,…
-
Second pass at: A history of disordered eating: proceeding carefully Replied, post #8 · Wellbeing › Mental health · 19 Feb 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Canadian access and provincial variation Replied, post #79 · Regional › North America · 11 Feb 2025 · 28 likes Worth separating two things that post #75 runs together. Cross-border purchase: buying in the US and bringing to Canada or vice versa involves both countries' import…
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #83 · Data & Tools › Calculators · 9 Feb 2025 · 25 likes Coming back to post #81, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
Dose numbers for oral formulations are not comparable to injectable ones — a second… Replied, post #20 · Compounds › Oral incretins · 4 Jan 2025 · 12 likes On post #16 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
Isotonicity and what happens when you get it wrong Replied, post #13 · Pharmacology › Formulation chemistry · 31 Dec 2024 · 0 likes Coming back to post #11, because the follow-up matters more than the original answer. Container closure: the vial material, rubber closure, and sealing all affect…
-
What we do not know about retatrutide, listed explicitly Replied, post #37 · Compounds › Retatrutide · 29 Dec 2024 · 2 likes Picking up post #34: that is the part I would want checked first. Hepatic effects: glucagon receptor agonism promotes hepatic fat oxidation, which is mechanistically…
-
Why mass spectrometry cannot tell you about an epimer Replied, post #14 · Analytics › Mass spectrometry · 29 Dec 2024 · 15 likes Coming back to post #12, because the follow-up matters more than the original answer. Calibration matters: a high-resolution instrument out of calibration can report…
-
Body image changing more slowly than the body Replied, post #129 · Wellbeing › Mental health · 25 Dec 2024 · 0 likes post #128 answers the question as asked. The question underneath it is different. Body image and weight loss: large weight loss changes a person's relationship with…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #50 · Sourcing › Regulatory · 24 Dec 2024 · 0 likes On post #46 — agreed on the reasoning, with one qualification. Preclinical versus clinical: compounds with strong preclinical data can fail in clinical trials.…
-
Converting between mg/mL and units per dose, both directions Replied, post #140 · Practice › Reconstitution · 21 Dec 2024 · 1 like The decimal-point error: computing 5 mg / 2 mL as 0.25 mg/mL instead of 2.5 mg/mL is the most common arithmetic error in this subcategory. The habit that catches it:…
-
Criticising the method without criticising the authors Replied, post #24 · Evidence › Study critique · 15 Dec 2024 · 7 likes Picking up post #21: that is the part I would want checked first. Multiple comparisons: if a paper reports many outcomes, the chance of a spurious association by random…
-
Revisiting: Moderation log format change Replied, post #65 · Meta › Announcements · 12 Dec 2024 · 3 likes On post #61 — agreed on the reasoning, with one qualification. Feedback to announcements: if you have feedback on an announced change (not a question, but your…
-
Second pass at: How to research a compound with no human data without deceiving yourself Replied, post #2 · Compounds › Other compounds · 30 Nov 2024 · 3 likes the opening post answers the question as asked. The question underneath it is different. When "no data" is the complete and final answer: if there is no published human…
-
Time to steady state after a dose increase Replied, post #141 · Pharmacology › Pharmacokinetics · 6 Nov 2024 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #2 · Clinical › Comorbidities · 7 Oct 2024 · 15 likes Worth separating two things that the opening post runs together. Interactions between comorbidities: diabetes and kidney disease together change the risk calculation…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #76 · Clinical › Bloodwork · 3 Oct 2024 · 4 likes TSH and free hormones: TSH is a reasonable screening test but does not tell you about actual free hormone levels. If TSH is abnormal, free thyroid hormones confirm…
-
Hepatic effects of glucagon receptor agonism: the mechanistic worry Replied, post #31 · Compounds › Retatrutide · 11 Sep 2024 · 17 likes On post #27 — agreed on the reasoning, with one qualification. TRIUMPH is phase 3 and it is ongoing. No phase 3 results exist. Nothing should be attributed to TRIUMPH…
-
How to ask for a dose change without antagonising anyone Replied, post #21 · Clinical › Prescriber conversations · 2 Sep 2024 · 5 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #30 · Sourcing › Independent verification · 1 Sep 2024 · 27 likes VendorInvestigate: documentation and supplier-practice review. Reviews paperwork rather than vials. Tells you something about a supplier's systems but says nothing…
-
[2026 update] People with a low starting BMI: where the evidence stops Replied, post #3 · Clinical › Special populations · 26 Aug 2024 · 5 likes I read the opening post twice before replying, because I had assumed the opposite. Adolescents: a distinct evidence base exists. The compounds are not approved for…
-
Assessing a warm arrival: the decision process — one year on Replied, post #107 · Sourcing › Logistics · 1 Jun 2024 · 1 like Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…